SEARCH

SEARCH BY CITATION

References

  • [1]
    Manners, D.J, Masson, A.J, Patterson, J.C (1973) The structure of a beta-(1[RIGHTWARDS ARROW]3)-d-glucan from yeast cell walls. Biochem. J. 135, 1930.
  • [2]
    Bhatty, R.S (1993) Extraction and enrichment (1[RIGHTWARDS ARROW]3),(1[RIGHTWARDS ARROW]4)-beta-d-glucan from barley and oat brans. Cereal Chem. 70, 7377.
  • [3]
    Xia, Y, Vetvicka, V, Yan, J, Hanikyrova, M, Mayadas, T, Ross, G.D (1999) The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. J. Immunol. 162, 22812290.
  • [4]
    Brown, G.D, Gordon, S (2001) Immune recognition. A new receptor for beta-glucans. Nature 413, 3637.
  • [5]
    Thornton, B.P, Vetvicka, V, Pitman, M, Goldman, R.C, Ross, G.D (1996) Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J. Immunol. 156, 12351246.
  • [6]
    Vetvicka, V, Thornton, B.P, Wieman, T.J, Ross, G.D (1997) Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and β-glucan-primed CR3 (CD11b/CD18). J. Immunol. 159, 599605.
  • [7]
    Le Cabec, V, Cols, C, Maridonneau-Parini, I (2000) Nonopsonic phagocytosis of zymosan and mycobacterium kansasii by CR3 (CD11b/CD18) involves distinct molecular determinants and is or is not coupled with NADPH oxidase activation. Infect. Immun. 68, 47364745.
  • [8]
    Benach, J.L, Habicht, G.S, Holbrook, T.W, Cook, J.A (1982) Glucan as an adjuvant for a murine Babesia microti immunization trial. Infect. Immun. 35, 947951.
  • [9]
    Ormstad, H, Groeng, E.C, Lovik, M, Hetland, G (2000) The fungal cell wall component beta-1,3-glucan has an adjuvant effect on the allergic response to ovalbumin in mice. J. Toxicol. Environ. Health. A 61, 5567.
  • [10]
    Cross, G.G, Jennings, H.J, Whitfield, D.M, Penney, C.L, Zacharie, B, Gagnon, L (2001) Immunostimulant oxidized beta-glucan conjugates. Int. Immunopharmacol. 1, 539550.
  • [11]
    Konopski, Z, Rasmussen, L.T, Seljelid, R, Eskeland, T (1991) Phagocytosis of beta-1,3-d-glucan-derivatized microbeads by mouse peritoneal macrophages involves three different receptors. Scand. J. Immunol. 33, 297306.
  • [12]
    Onderdonk, A.B, Cisneros, R.L, Hinkson, P, Ostroff, G (1992) Anti-infective effect of poly-beta 1-6-glucotriosyl-beta 1–3-glucopyranose glucan in vivo. Infect. Immun. 60, 16421647.
  • [13]
    Seljelid, R, Rasmussen, L.T, Larm, O, Hoffman, J (1987) The protective effect of beta 1–3-d-glucan-derivatized plastic beads against Escherichia coli infection in mice. Scand. J. Immunol. 25, 5560.
  • [14]
    Reichner, J.S, Fitzpatrick, P.A, Wakshull, E, Albina, J.E (2001) Receptor-mediated phagocytosis of rat macrophages is regulated differentially for opsonized particles and non-opsonized particles containing beta-glucan. Immunology 104, 198206.
  • [15]
    Bogwald, J, Johnson, E, Hoffman, J, Seljelid, R (1984) Lysosomal glycosidases in mouse peritoneal macrophages stimulated in vitro with soluble and insoluble glycans. J. Leukoc. Biol. 35, 357371.
  • [16]
    Tapper, H, Sundler, R (1995) Glucan receptor and zymosan-induced lysosomal enzyme secretion in macrophages. Biochem. J. 306, 829835.
  • [17]
    Doita, M, Rasmussen, L.T, Seljelid, R, Lipsky, P.E (1991) Effect of soluble aminated beta-1,3-d-polyglucose on human monocytes: stimulation of cytokine and prostaglandin E2 production but not antigen-presenting function. J. Leukoc. Biol. 49, 342351.
  • [18]
    Estrada, A, van Kessel, A, Yun, C.H, Li, B (1998) Effect of endotoxin on cytokine production and cell dynamics in mice. Immunopharmacol. Immunotoxicol. 20, 217231.
  • [19]
    Czop, J.K, Austen, K.F (1985) Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor. J. Immunol. 135, 33883393.
  • [20]
    Fitzgerald, P.R. (1980) The economic impact of coccidiosis in domestic animals. In: Advances in Veterinary Science and Comparative Medicine, Vol. 24 (Brandly, C.A. and Cornelius, C.E., Eds.), pp. 121–143. Academic Press, New York.
  • [21]
    Chapman, H.D (2001) Use of anticoccidial drugs in broiler chickens in the USA: analysis for the years 1995 to 1999. Poult. Sci. 80, 572580.
  • [22]
    Kluytmans, J.A, Mouton, J.W, Ijzerman, E.P, Vandenbroucke-Grauls, C.M, Maat, A.W, Wagenvoort, J.H, Verbrugh, H.A (1995) Nasal carriage of Staphylococcus aureus as a major risk factor for the development of wound infections after cardiac surgery. J. Infect. Dis. 171, 216219.
  • [23]
    Bishara, J, Leibovici, L, Gartman-Israel, D, Sagie, A, Kazakov, A, Miroshnik, E, Ashkenazi, S, Pitlik, S (2001) Long-term outcome of infective endocarditis: the impact of early surgical intervention. Clin. Infect. Dis. 15, 16361643.
  • [24]
    Liu, Z.Q, Deng, G.M, Foster, S, Tarkowski, A (2001) Staphylococcal peptidoglycans induce arthritis. Arthritis Res. 3, 375380.
  • [25]
    Rahal, J.J (2001) Short-term therapy for intravascular catheter-related Staphylococcus aureus bacteremia. Clin. Infect. Dis. 33, 19461951.
  • [26]
    Chapman, H.D (1998) Evaluation of the efficacy of anticoccidial drugs against Eimeria species in the fowl. Int. J. Parasitol. 28, 11411144.
  • [27]
    Bradley, S.F (2002) Staphylococcus aureus infections and antibiotic resistance in older adults. Clin. Infect. Dis. 34, 211216.
  • [28]
    Tenover, F.C, Biddle, J.W, Lancaster, M.V (2001) Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg. Infect. Dis. 7, 327332.
  • [29]
    Yun, C.H, Estrada, A, Gajadhar, A.A, Redmond, M.J, Laarveld, B (1996) Passive immunization against somatostatin increases resistance to Eimeria vermiformis infection in susceptible mice. Comp. Immunol. Microbiol. Inf. Dis. 19, 3946.
  • [30]
    Estrada, A, Yun, C.H, van Kessel, A, Li, B, Hauta, S, Laarveld, B (1997) Immunomodulatory activities of oat β-glucan in vitro and in vivo. Microbiol. Immunol. 41, 991998.
  • [31]
    Yun, C.H, Estrada, A, van Kessel, A, Gajadhar, A.A, Redmond, M.J, Laarveld, B (1997) β-(1,3)(1,4) oat glucan enhances resistance to Eimeria vermiformis infection in immunosuppressed mice. Int. J. Parasitol. 27, 329337.
  • [32]
    Rose, M.E, Millard, B.J (1985) Eimeria vermiformis: Host strains and the development cycle. Exp. Parasitol. 60, 285293.
  • [33]
    Hashimoto, K, Suzuki, I, Yadomae, T (1991) Oral administration of SSG, a beta-glucan obtained from Sclerotinia sclerotiorum, affects the function of Peyer's patch cells. Int. J. Immunopharmacol. 13, 437442.
  • [34]
    Obaid, K.A, Ahmad, S, Khan, H.M, Mahdi, A.A, Khanna, R (1989) Protective effect of L. donovani antigens using glucan as an adjuvant. Int. J. Immunopharmacol. 11, 229235.
  • [35]
    Reynolds, J.A, Kastello, M.D, Harrington, D.G, Crabbs, C.L, Peters, C.J, Jemski, J.V, Scott, G.H, Di Luzio, N.R (1980) Glucan-induced enhancement of host resistance to selected infectious diseases. Infect. Immun. 30, 5157.
  • [36]
    Williams, D.L, Yaeger, R.G, Pretus, H.A, Browder, I.W, McNamee, R.B, Jones, E.L (1989) Immunization against Trypanosoma cruzi: Adjuvant effect of glucan. Int. J. Immunopharmacol. 11, 403410.
  • [37]
    Rose, M.E, Owen, D.G, Hesketh, P (1984) Susceptibility to coccidiosis: Contrasting course of primary infections with Eimeria vermiformis in BALB/c and C57BL/6 mice is based on immune responses. Parasite Immunol. 7, 557566.
  • [38]
    Smith, A.L, Hayday, A.C (2000) Genetic dissection of primary and secondary responses to a widespread natural pathogen of the gut, Eimeria vermiformis. Infect. Immun. 68, 62736280.